Literature DB >> 911862

Purification of proenzymic and activated human C1s free ofC1r. Effect of calcium and ionic strength on activated C1s.

G J Arlaud, A Reboul, C M Meyer, M G Colomb.   

Abstract

1. A rapid method for the purification of the proenzymic and activated forms of C1s is presented. In the case of proenzymic C1s, di-isopropyl phosphorofluoridate (0.5--5 mM) is added at all stages of the purification procedure, which includes euglobulin precipation followed by DEAE-cellulose chromatography and affinity chromatography on anti-C1r IgG-Sepharose 6B. The final step completely removes contaminant traces of C1r and/or C1r, ensuring that the final preparation of C1s is stable in the proenzyme form and suitable for activation studies. 2. The apparent molecular weight of C1s and C1s determined by sodium dodecyl sulphate polyacrylamide gel electrophoresis is 85 000 +/- 2000. Reduction followed by alkylation of C1s gives two fragments of apparent molecular weights 57 000 and 28 000. Results of N-terminal amino acid determination and labelling with di-iso[3H]propyl phosphorofluoridate are consistent with previous reports. 3. The influence of calcium and ionic strength on the structure and activity of C1s has been investigated. Calcium leads to a shift of the sedimentation coefficient from 4.3 to 5.6 S, whereas variation in ionic strength has no effect on this parameter. The thermal inactivation curve is profoundly modified both by calcium and ionic strength. In contrast, the esterase activity is only slightly influenced as judged from the absence of gross modification of Km and V.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 911862     DOI: 10.1016/0005-2744(77)90208-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation.

Authors:  Umakhanth Venkatraman Girija; Alexandre R Gingras; Jamie E Marshall; Roshni Panchal; Md Arif Sheikh; James A J Harper; Péter Gál; Wilhelm J Schwaeble; Daniel A Mitchell; Peter C E Moody; Russell Wallis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-06       Impact factor: 11.205

2.  Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement.

Authors:  C L Villiers; G J Arlaud; M G Colomb
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

3.  Activation of the first component of human complement (C1) by antibody-antigen aggregates.

Authors:  A W Dodds; R B Sim; R R Porter; M A Kerr
Journal:  Biochem J       Date:  1978-11-01       Impact factor: 3.857

4.  The purification and characterization of subcomponent C1s of the first component of bovine complement.

Authors:  R D Campbell; N A Booth; J E Fothergill
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

5.  Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.

Authors:  S Chesne; C L Villiers; G J Arlaud; M B Lacroix; M G Colomb
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

6.  Soluble C3 proconvertase and convertase of the classical pathway of human complement. Conditions of stabilization in vitro.

Authors:  M B Villiers; N M Thielens; M G Colomb
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

7.  Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.

Authors:  J C Bensa; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.